HIV, HAART and overseas visitors

Sexually Transmitted Infections

Volumn 82, Issue 6, 2006, Pages 516-

  Fowler, A ^a   Collins, L ^a   Larbalestier, N ^a   Kulasegaram, R ^a   De Ruiter, A ^a   Micunovic, V ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL FEATURE; DIAGNOSTIC TEST; HEALTH CARE COST; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; PUBLIC HEALTH;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; GREAT BRITAIN; HIV INFECTIONS; HUMANS; TRANSIENTS AND MIGRANTS;

EID: 33845871974     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2006.021766     Document Type: Letter

References (5)

1. Department of Health. Implementing the Overseas Visitors Hospital Charging Regulations for NHS Trust Hospitals in England. London: DoH, 2004, http://www.dh.gov.uk/assetRoot/04/10/60/24/04106024.pdf (accessed 8 Oct 2006).
2. http://www.hpo.org.uk/publications/2005/hiv_sti_2005/pdf/Mtl_FC_report. pdf.
3. Pollard AJ, Savulescu J. Ethics in practice: eligibility of overseas visitors and people of uncertain residential status for NHS treatment. BMJ 2004;329:346-9.
4. Williams PD. Why failed asylum seekers must not be denied access to the NHS. BMJ 2004;329:298.
5. Valenti WM. HIV disease management: new technologies improve outcomes and contain costs. AIDS Read 2002;12:64-6.